Home
Who We Are
Who We Are
Testimonials
Collaborations
Consulting
Inspection Readiness
GxP Auditing
Quality Systems
Quality Risk Management
Monitoring Services
Training
GCP Training Services
Training Courses
DIGR-ACT
DIGR-ACT - Home
DIGR-ACT - About
DIGR-ACT - Contact Us
Online Store
Catalog
Blog
Contact

Clinical Pathways

Home
Who We Are
Who We Are
Testimonials
Collaborations
Consulting
Inspection Readiness
GxP Auditing
Quality Systems
Quality Risk Management
Monitoring Services
Training
GCP Training Services
Training Courses
DIGR-ACT
DIGR-ACT - Home
DIGR-ACT - About
DIGR-ACT - Contact Us
Online Store
Catalog
Blog
Contact
February 3, 2026
Guest User
FDA Releases Final Guidance on ICH E6(R3)

02/03/2026

-

On September 8th, 2025, the US Food and Drug Administration (FDA) released their final guidance for industry on the ICH E6(R3) Good Clinical Practice (GCP). ICH E6(R3) Principles and Annex 1 were finalized on January 6th, 2025, officially taking over the preceding 2016 ICH E6(R2). Annex 2 is expected to be finalized in early 2026.

FDA Releases Final Guidance on ICH E6(R3)
January 8, 2026
Guest User
Finalized Guidance for Industry: Investigator ...

01/08/2026

-

On December 15th, 2025, the US Food and Drug Administration (FDA) released the finalized guidance for industry “Investigator Responsibilities — Safety Reporting for Investigational Drugs and Devices”. Unlike most updates, this finalized guidance is replacing the FDA’s recommendations from two separate final guidance documents: “Safety Reporting Requirements for INDs and BA/BE Studies” from 2012 and “Adverse Event Reporting to IRBs—Improving Human Subject Protection” from 2009, both of which are now withdrawn.

Finalized Guidance for Industry: Investigator Responsibilities for Safety Reporting
December 2, 2025
Guest User
EU Commission Releases Draft Annex 11: ...

12/02/2025

-

On July 7, 2025, the European Union (EU) Commission and Pharmaceutical Inspection Co-operation Scheme (PIC/S) published an updated draft of Annex 11: Computerised Systems, a supplementary guideline that is part of the Good Manufacturing Practice (GMP). Although it is GMP focused, the guiding principles of the annex can also be applied to other GxP standards.

EU Commission Releases Draft Annex 11: Computerised Systems
November 18, 2025
Guest User
Warning Letter Issued to Investigator of ...

11/18/2025

-

In July, 2025, the US Food and Drug Administration (FDA) issued a warning letter to an investigator conducting a clinical trial for pediatric participants. The warning letter was the result of a routine inspection part of the FDA’s Bioresearch Monitoring Program (BIMO) as well as the investigator’s written response to the Form FDA 483.

Warning Letter Issued to Investigator of Pediatric Study
November 6, 2025
Guest User
ISO Release DIS 9001:2026 for Quality ...

11/06/2025

-

On August 27, 2025, the International Organization for Standardization (ISO) released a Draft International Standard (DIS) for the ISO 9001:2026 Quality Management Systems (QMS) to ISO member bodies for a twelve-week review and ballot period. The goal of ISO 9001 is to help organizations create and maintain consistency of their products or services and seeks to improve and refine their internal processes and procedures to increase efficiency.

ISO Release DIS 9001:2026 for Quality Management Systems
Sandra Sather
August 24, 2015

“Monitoring Electronic Health Records (EHRs): Frequently Asked Questions Attend the Sep 9th WEB Session”

Sandra Sather
August 24, 2015

08/24/2015

Looking to discover clear, practical answers to Frequently Asked Questions about Monitoring Electronic Health Records (EHR). Register today before it's too late!

Sandra Sather
July 1, 2015

New Investigator Warning Letter / Also for OUS Investigator

Sandra Sather
July 1, 2015

07/01/2015

A very interesting FDA Warning Letter (WL) has been posted to an Investigator located in France. Take a look!

Sandra Sather
June 24, 2015

Electronic Informed Consent / August 10th

Sandra Sather
June 24, 2015

06/24/2015

For those that manage clinical trials, collecting informed consent through traditional paper-based methods is quickly becoming outdated. Electronic media offers many advantages for both patients and the advancement of scientific research.

Sandra Sather
June 19, 2015

New Technology for Remote Monitoring! Event Monday June 22nd 6:30pm

Sandra Sather
June 19, 2015

06/19/2015

Promeditec has developed a package that enables the user to carry out remote monitoring of clinical trials. Virtual On Site Monitoring (VOS) integrates high-cost traditional monitoring with an innovative method that leads to significant reduction in time and cost by eliminating the need for monitor relocation. 

Sandra Sather
June 2, 2015

The Modern Risk Based Monitor! Sing Along.

Sandra Sather
June 2, 2015

06/02/2015

Thank you, Laurie Meehan!

Newer Posts
Older Posts
 
Archive List
  • 2013 6
  • 2014 31
  • 2015 25
  • 2016 21
  • 2017 31
  • 2018 55
  • 2019 56
  • 2020 63
  • 2021 50
  • 2022 39
  • 2023 27
  • 2024 25
  • 2025 31
  • 2026 2

Subscribe to Blogs and Newsletters.

By signing up, you agree to our our Privacy Policy. You may unsubscribe from emails at any time.

Thank you! You will receive a confirmation email shortly.

Back to Top
Clinical Pathwaysinfo@clinicalpathwaysresearch.com

Cookie Notice | License Agreement | Privacy Policy | Return Policy | Terms and Conditions | Data Security Policy | Confidentiality Policy

© 2026 Clinical Pathways. All rights reserved.